Lessons Learned From the Development of Oral Calcitonin: The First Tablet Formulation of a Protein in Phase III Clinical Trials

Biochemical markers and the FDA Critical Path: How biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development

(2009) M.A. Karsdal et al.   BIOMARKERS

Influence of food intake on the bioavailability and efficacy of oral calcitonin

(2009) Morten A. Karsdal et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Orally Administered Glucagon-Like Peptide-1 Affects Glucose Homeostasis Following an Oral Glucose Tolerance Test in Healthy Male Subjects

(2009) R E Steinert et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Investigations of inter- and intraindividual relationships between exposure to oral salmon calcitonin and a surrogate marker of pharmacodynamic efficacy

(2009) Morten A. Karsdal et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Lipeo-sCT: A novel reversible lipidized salmon calcitonin derivative, its biophysical properties and hypocalcemic activity

(2009) Weiqiang Cheng et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

A Pharmacokinetic and Pharmacodynamic Comparison of Synthetic and Recombinant Oral Salmon Calcitonin

(2009) Morten A. Karsdal et al.   JOURNAL OF CLINICAL PHARMACOLOGY

The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study

(2009) M.A. Karsdal et al.   OSTEOARTHRITIS AND CARTILAGE

Identification of progressors in osteoarthritis by combining biochemical and MRI-based markers

(2009) Erik B Dam et al.   ARTHRITIS RESEARCH & THERAPY

Calcitonin ??? A Drug of the Past or for the Future?

(2008) Morten A Karsdal et al.   BIODRUGS

Evaluation of cartilage damage by measuring collagen degradation products in joint extracts in a traumatic model of osteoarthritis

(2008) Rasmus H. Nielsen et al.   BIOMARKERS

Synthesis, Characterization and In Vivo Activity of Salmon Calcitonin Coconjugated With Lipid and Polyethylene Glycol

(2008) Weiqiang Cheng et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI

(2008) E.B. Dam et al.   OSTEOARTHRITIS AND CARTILAGE

The effects of oral calcitonin on bone collagen maturation: implications for bone turnover and quality

(2008) M. A. Karsdal et al.   OSTEOPOROSIS INTERNATIONAL